MYNZ Stock Analysis: Buy, Sell, or Hold?
MYNZ - Mainz Biomed N.V. Ordinary Shares
$1.13
-0.06 (-5.04%)
▼
5d:
-13.08%
30d:
+0.89%
90d:
-24.67%
WAIT
LOW Confidence
Last Updated: February 2, 2026
Earnings: Apr 07, 2026
Get Alerted When MYNZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MYNZ is down 13.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MYNZ is down 13.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MYNZ is currently trading at $1.13, which is considered oversold relative to its 30-day fair value range of $1.13 to $1.25.
Technical Outlook: Technically, MYNZ is in a strong downtrend. Immediate support is located at $1.08, while resistance sits at $1.60. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: MYNZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.00 (+1138.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYNZ is in a strong downtrend. Immediate support is located at $1.08, while resistance sits at $1.60. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: MYNZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.00 (+1138.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.13 -
$1.25
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.0%)
- BULLISH: Trading 1138.9% below Wall St target ($14.00)
- WARNING: Recommendation downgraded due to -13.1% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.13 -
$1.25
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.08
Resistance Level
$1.60
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.84
Wall Street Target
$14.00
(+1138.9%)
Revenue Growth (YoY)
-44.9%
Last updated: February 02, 2026 5:50 PM ET
Data refreshes hourly during market hours. Next update: 6:50 PM
Data refreshes hourly during market hours. Next update: 6:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYNZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$666 | 49 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 51 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$125 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 55 HOLD |
